Skip to content

Herbal Patch for Overactive Bladder

Clinical Evaluation of Herbal Patch for Overactive Bladder Patients

Status
Completed
Phases
Phase 2Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03532789
Enrollment
66
Registered
2018-05-22
Start date
2018-05-14
Completion date
2019-10-23
Last updated
2019-10-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Overactive Bladder Syndrome

Brief summary

Overactive bladder is a clinical syndrome characterized by frequency, with or without urge incontinence, urgency, and nocturia, which affect patients' sleeping quality and rehabilitation program progressing. Current treatments include behavioral therapy (eg, life style adjustment, bladder training, pelvic floor muscle therapy) and medication. Antimuscarinic agents is the most common medications prescribed for OAB, but patients often have side effects like dry mouth and constipation. And there were plenty of herbal medicine which are beneficial to urine frequency and voiding dysfunction in ancient Chinese medicine books and records. In human trial, 62 Subjects diagnosed as overactive bladder will be enrolled and treated with Cinnamon patch. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis.

Detailed description

Overactive bladder is a clinical syndrome characterized by frequency, with or without urge incontinence, urgency, and nocturia, which affect patients' sleeping quality and rehabilitation program progressing. Current treatments include behavioral therapy (eg, life style adjustment, bladder training, pelvic floor muscle therapy) and medication. Antimuscarinic agents is the most common medications prescribed for OAB, but patients often have side effects like dry mouth and constipation. And there were plenty of herbal medicine which are beneficial to urine frequency and voiding dysfunction in ancient Chinese medicine books and records. In human trial, 62 Subjects diagnosed as overactive bladder will be enrolled and treated with Cinnamon patch. After treatment we will estimate the efficacy and record adverse events to conduct statistically analysis. The 1st year project: (1) Expect to enroll 62 clinical subjects of OAB. (2) Evaluate subjects 'symptom and proceed patch treatment. (3) Record treatment responses including adverse effect. (4) Conduct statistically analysis. The 2nd year project: (1) Completing enrollment of 62 clinical subjects of OAB. (2) Finish evaluation and treatment of all subjects. (3) Statistically analysis all collecting data (4) Discuss and analyze the outcome.

Interventions

One patch with medicine should be applied to the skin every other day within two weeks

DRUGplacebo patch

One patch without medicine should be applied to the skin every other day within two weeks

Sponsors

En Chu Kong Hospital
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Intervention model description

overactive bladder patients

Eligibility

Sex/Gender
ALL
Age
20 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* urgency score of OABSS ≥ 2 or total score of OABSS ≥ 3

Exclusion criteria

* suffering from acute urinary tract infection * recurrent urinary tract infection ≥ 5 times in the last year * Hematuria or bladder stone disease * using foley catheter * Pregnant or breastfeeding women * Spinal cord injury patients * Mental illness or substance abuse * taking medicine for the treatment of overactive bladder within one month

Design outcomes

Primary

MeasureTime frameDescription
OABSSChange from Baseline OABSS at 2weeksOveractive bladder symptom score, questionnaire

Secondary

MeasureTime frameDescription
PPBCChange from Baseline PPBC at 2weeksPatient perception of bladder condition, questionnaire
USSChange from Baseline USS at 2weeksUrgency Severity Scale, questionnaire
TCMBCQChange from Baseline TCMBCQ at 2weeksTraditional Chinese Medicine Body Constitution Questionnaire

Countries

Taiwan

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026